Promoting intestinal regeneration without tumor risk in immune-mediated inflammatory diseases

Area of Science:

• Gastroenterology and Immunology
• Cellular Biology
• Oncology

Background:

• Immune-mediated inflammatory disorders, like inflammatory bowel diseases (IBD), involve chronic gut inflammation and barrier damage.
• Current IBD treatments reduce inflammation but often cause side effects and fail to induce remission.
• Therapeutic strategies targeting intestinal regeneration are promising but risk promoting tumorigenesis.

Purpose of the Study:

• To review common mechanisms underlying intestinal regeneration and tumor development.
• To discuss recent findings on cellular and molecular pathways that selectively promote regeneration over tumorigenesis.

Main Methods:

• Literature review of studies on intestinal regeneration and cancer development.
• Analysis of cellular and molecular pathways involved in both processes.
• Synthesis of current research identifying distinct regenerative and tumorigenic pathways.

Main Results:

• Identified shared pathways crucial for both intestinal regeneration and tumor growth.
• Highlighted the dual role of regenerative pathways in normal tissue repair and cancer.
• Discussed emerging research focusing on pathways that decouple regeneration from tumorigenesis.

Conclusions:

• Selective activation of specific regenerative pathways could offer safer therapeutic strategies for IBD.
• Further research is needed to fully understand and exploit pathways that promote regeneration without oncogenic risk.
• Targeting these distinct pathways holds potential for novel, effective, and safer treatments for chronic inflammatory intestinal diseases.